IT1391588B1 - Composizione sinergica per il recupero e la riduzione del danno ischemico lieve - Google Patents

Composizione sinergica per il recupero e la riduzione del danno ischemico lieve

Info

Publication number
IT1391588B1
IT1391588B1 ITMI2008A001830A ITMI20081830A IT1391588B1 IT 1391588 B1 IT1391588 B1 IT 1391588B1 IT MI2008A001830 A ITMI2008A001830 A IT MI2008A001830A IT MI20081830 A ITMI20081830 A IT MI20081830A IT 1391588 B1 IT1391588 B1 IT 1391588B1
Authority
IT
Italy
Prior art keywords
lieve
recovery
reduction
ischemic damage
synergic composition
Prior art date
Application number
ITMI2008A001830A
Other languages
English (en)
Inventor
Carlo Terruzzi
Franco Lucchina
Original Assignee
Giellepi Chemicals S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giellepi Chemicals S P A filed Critical Giellepi Chemicals S P A
Priority to ITMI2008A001830A priority Critical patent/IT1391588B1/it
Priority to PCT/IB2009/054534 priority patent/WO2010044070A2/en
Priority to EP09795546.2A priority patent/EP2349249B1/en
Publication of ITMI20081830A1 publication Critical patent/ITMI20081830A1/it
Application granted granted Critical
Publication of IT1391588B1 publication Critical patent/IT1391588B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Detergent Compositions (AREA)
ITMI2008A001830A 2008-10-15 2008-10-15 Composizione sinergica per il recupero e la riduzione del danno ischemico lieve IT1391588B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI2008A001830A IT1391588B1 (it) 2008-10-15 2008-10-15 Composizione sinergica per il recupero e la riduzione del danno ischemico lieve
PCT/IB2009/054534 WO2010044070A2 (en) 2008-10-15 2009-10-15 Synergistic composition for recovery and reduction of mild ischemic damage
EP09795546.2A EP2349249B1 (en) 2008-10-15 2009-10-15 Synergistic composition for recovery and reduction of mild ischemic damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2008A001830A IT1391588B1 (it) 2008-10-15 2008-10-15 Composizione sinergica per il recupero e la riduzione del danno ischemico lieve

Publications (2)

Publication Number Publication Date
ITMI20081830A1 ITMI20081830A1 (it) 2010-04-16
IT1391588B1 true IT1391588B1 (it) 2012-01-11

Family

ID=40599995

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2008A001830A IT1391588B1 (it) 2008-10-15 2008-10-15 Composizione sinergica per il recupero e la riduzione del danno ischemico lieve

Country Status (3)

Country Link
EP (1) EP2349249B1 (it)
IT (1) IT1391588B1 (it)
WO (1) WO2010044070A2 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20100734A1 (it) * 2010-12-14 2012-06-15 Eliseo Garuti Composizione per il trattamento e la prevenzione della degenerazione cellulare

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719201A (en) * 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
NZ222051A (en) * 1986-10-06 1990-07-26 Univ Virginia Solution containing adenosine or hypoxanthine and optionally ribose for heart protection during surgery
US5091404A (en) * 1990-10-05 1992-02-25 Elgebaly Salwa A Method for restoring functionality in muscle tissue
UA28064C2 (uk) * 1996-12-26 2000-10-16 Акціонерне Товариство Закритого Типу "Фармацевтична Фірма Млк" Калієві солі різнолігандних координаційних сполук магнію з гістидином і аденозин-5'-трифосфатом або креатинфосфатом, що проявляють захисну дію на міокард від ішемічного ушкодження
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6172114B1 (en) * 1999-09-30 2001-01-09 Worldwide Sports Nutritional Supplements, Inc. Creatine supplement
AU2001278197A1 (en) * 2000-07-28 2002-02-13 Bioenergy Inc. Compositions and methods for improving cardiovascular function
WO2007146086A1 (en) * 2006-06-06 2007-12-21 Xenoport, Inc. Creatine prodrugs, compositions and uses thereof

Also Published As

Publication number Publication date
WO2010044070A3 (en) 2010-08-19
WO2010044070A2 (en) 2010-04-22
ITMI20081830A1 (it) 2010-04-16
EP2349249B1 (en) 2017-04-05
EP2349249A2 (en) 2011-08-03

Similar Documents

Publication Publication Date Title
BRPI1014965A2 (pt) “artigo e composição para revestimento”
BRPI1010079A2 (pt) composição e artigo
BR112012001604A2 (pt) composição para cuidado pessoal
BRPI0920284A2 (pt) composição e método
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BR112012002247A2 (pt) composição e artigo
BRPI0913945A2 (pt) agentes anti-inflamatórios
DK2373293T3 (da) Sammensætninger med reduceret dimerdannelse
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BRPI0917231A2 (pt) composição
BRPI0918328B8 (pt) composição e artigo
BRPI0913807A2 (pt) composição e artigo
BR112012005678A2 (pt) composição para cuidado pessoal
BRPI0919493A2 (pt) composição dentifrícia
DK2240154T3 (da) Kosmetisk sammensætning omfattende glycogentil anvendelse med fløjlsblød virkning
BRPI0909218A2 (pt) composição tensoativas
ATE534721T1 (de) Reinigungsmittelzusammensetzung
BRPI0912074A2 (pt) composto e composição farmacêutica
BRPI0908497A2 (pt) métodos e composições para um rendimento aumentado
BR112012014239A2 (pt) composição para cuidado pessoal
BRPI0917584A2 (pt) composição
BRPI0822200A2 (pt) Composição pupicida e e larvicida
IT1391588B1 (it) Composizione sinergica per il recupero e la riduzione del danno ischemico lieve
BRPI0920692A2 (pt) composição